NCT03454334

Visual Performance of Four Types of Multifocal Intraocular Lenses

To Compare the Clinical Results of Different Multifocal Intraocular Lenses (IOLs) in Patients With Presbyopia or Cataracts

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 141 (actual)
• Sponsor: Shahid Beheshti University · Academic / Other
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This investigation assessed the visual performance of presbyopia and cataract patients after bilateral implantation of 4 distinct sorts of multifocal IOLs: At lisa tri, PanOptix, ReSTOR, and Symfony. The clinical results demonstrated here were excellent for four groups, however, there were also differences in group ReSTOR, UCVA and BCVA for the intermediate and near of the other groups showed less vision also symphony group for far distance demonstrated less vision than other groups, which may be related to their design.Multifocal IOLs demonstrated very good technology and unquestionably have a place in refractive surgery, whether for clear lens extraction or cataracts.Patients can expect excellent outcomes and surgeons can expect patients to be very satisfied with surgical outcomes. Four groups multifocal lenses provided excellent distance, intermediate and near vision, but several measures indicated that the PanOptix and at lisa tri lens provided better vision in all distances. Spectacle independence was significantly higher with four groups. Multifocal IOL design might play a role in the postsurgical outcome, because better results were obtained with diffractive lenses. Although there were differences in the results of these four lenses in the study, all of the results were acceptable.

Conditions

• Cataract

Interventions

Type	Name	Description
DEVICE	multifocal intraocular lens IOLs	clinical outcome of different multifocal intraocular lenses (IOLs) in patients with presbyopia or cataracts

Timeline

• Start date: 2013-08-11
• Primary completion: 2019-11-18
• Completion: 2020-01-14
• First posted: 2018-03-05
• Last updated: 2022-04-18

Regulatory

• FDA-regulated device study